Showing results (171-180 of 279) with videos related to

Sort By:
Pageof 28
FEBS Letters|December 17, 2009
Glyceraldehyde-3-phosphate dehydrogenase tetramer dissociation and amyloid fibril formation induced by negatively charged membranesLeonardo M Cortez, César L Avila, Clarisa M Torres Bugeau, et al.
Parasite Immunology|March 10, 2001
Immune responses to multiple antigen peptides containing T and B epitopes from Plasmodium falciparum circumsporozoite protein of Brazilian individuals naturally exposed to malariaS L Avila, A C Goldberg, V G Arruk, et al.
Vaccine|December 14, 2021
Epidemiology of pertussis in Costa Rica and the impact of vaccination: A 58-year experience (1961-2018)María L Avila-Agüero, Kattia Camacho-Badilla, Rolando Ulloa-Gutierrez, et al.
Neurology and Therapy|February 15, 2023
COVID-19 Vaccine Response in People with Multiple Sclerosis Treated with Dimethyl Fumarate, Diroximel Fumarate, Natalizumab, Ocrelizumab, or Interferon Beta TherapyAliya Jaber, Meera Patel, Andrew Sylvester, et al.
BMC Public Health|May 10, 2019
Burden of varicella in Latin America and the Caribbean: findings from a systematic literature reviewLuiza Helena Falleiros Arlant, Maria Catalina Pirez Garcia, Maria L Avila Aguero, et al.
Revista Alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)|January 21, 2000
[Wheezing in infants]N I Reyes Ruiz, B Estela del Río Navarro, L Avila Castañón, et al.
Revista Alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)|June 29, 2000
[Procedure for bronchodynamic tests with inhaled allergens]J J Sienra Monge, B E del Río Navarro, M A Rosas Vargas, et al.
Neurology and Therapy|March 26, 2023
Long-Term Effectiveness and Safety of Natalizumab in African American and Hispanic/Latino Patients with Early Relapsing-Remitting Multiple Sclerosis: STRIVE Data AnalysisJai Perumal, Roumen Balabanov, Laura Balcer, et al.
Cytokine|August 12, 2004
Systemic host inflammatory and coagulation response in the Dengue virus primo-infectionMaría L Avila-Aguero, Claudio R Avila-Aguero, Suzane L Um, et al.
The Pediatric Infectious Disease Journal|October 1, 1991
The clinical and immunologic response of Chilean infants to Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine coadministered in the same syringe with diphtheria-tetanus toxoids-pertussis vaccine at two, four and six months of ageC Ferreccio, J Clemens, A Avendano, et al.
Pageof 28